CG Oncology, Inc. SEC filings CGON
CG Oncology, Inc. has 243 filings in SEC EDGAR's recent list, going back to Oct 27, 2023. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change
|
May 26, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2025 | Nov 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 5, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 26, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 24, 2024 | May 24, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Other events
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 16, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jan 30, 2024 | Jan 29, 2024 |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dallas, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1991792
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.